Cernunnos, a Novel Nonhomologous End-Joining Factor, Is Mutated in Human Immunodeficiency with Microcephaly
Dietke Buck(Délégation Paris 5), Patrick Revy(Inserm), Anne Durandy(Hôpital Necker-Enfants Malades), Alain Fischer(Inserm), Marie‐Claude Fondanèche(Délégation Paris 5), Markus Hufnagel(University Hospital Schleswig-Holstein), Özden Sanal(Hacettepe University), Arthur Bertin Barraud(Délégation Paris 5), Laurent Malivert(Délégation Paris 5), Jean‐Pierre de Villartay(Université Paris Cité), Françoise Le Deist(Centre National de la Recherche Scientifique), Régina de Chasseval(Hôpital Necker-Enfants Malades), Jean‐Louis Stephan(Institut d’Hématologie et d’Oncologie Pédiatrique), Alessandro Plebani(University of Brescia)
Cited by 702
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k